Next-step strategies for panic disorder refractory to initial pharmacotherapy: A 3-phase randomized clinical trial

Journal of Clinical Psychiatry

Volumn 70, Issue 11, 2009, Pages 1563-1570

  Simon, Naomi M ^a   Otto, Michael W ^b   Worthington, John J ^a   Hoge, Elizabeth A ^a   Thompson, Elizabeth H ^a   LeBeau, Richard T ^a   Moshier, Samantha J ^a   Zalta, Alyson K ^a   Pollack, Mark H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; ESCITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISABILITY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HAMILTON ANXIETY SCALE; HEADACHE; HUMAN; INSOMNIA; MALE; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PANIC; PANIC DISORDER SEVERITY SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REMISSION; RESTLESSNESS; SCORING SYSTEM; SEDATION; SELF REPORT; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VOMITING;

ADULT; ANTICONVULSANTS; CITALOPRAM; CLONAZEPAM; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PANIC DISORDER; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 72849136336     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04485blu     Document Type: Article

References (43)

1. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. doi:10.1001/archpsyc.62.6.593 PubMed (Pubitemid 40973434)
2. Pollack MH, Otto MW, Kaspi SP, et al. Cognitive behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry. 1994;55(5):200-205. PubMed
3. Katon WJ. Clinical practice: panic disorder. N Engl J Med. 2006;354(22):2360-2367. doi:10.1056/NEJMcp052466 PubMed
4. Kessler RC, Chiu WT, Jin R, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63(4):415-424. doi:10.1001/archpsyc.63.4.415 PubMed
5. Roy-Byrne PP, Craske MG, Stein MB. Panic disorder. Lancet. 2006;368(9540):1023-1032. doi:10.1016/S0140-6736(06)69418-X PubMed
6. Davidson JR, Moroz G. Pivotal studies of clonazepam in panic disorder. Psychopharmacol Bull. 1998;34(2):169-174. PubMed
7. Dhillon S, Scott LJ, Plosker GL. Escitalopram: a review of its use in the management of anxiety disorders. CNS Drugs. 2006;20(9):763-790. doi:10.2165/00023210-200620090-00010 PubMed (Pubitemid 44376343)
8. Lydiard RB, Steiner M, Burnham D, et al. Efficacy studies of paroxetine in panic disorder. Psychopharmacol Bull. 1998;34(2):175-182. PubMed
9. Rapaport MH, Davidson JR. The efficacy of new pharmacological treatments for panic disorder: evaluating the trials. Psychopharmacol Bull. 1998;34(2):167-168. PubMed
10. Shear MK, Brown TA, Barlow DH, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry. 1997;154(11):1571-1575. PubMed
11. Shear MK, Maser JD. Standardized assessment for panic disorder research: a conference report. Arch Gen Psychiatry. 1994;51(5):346-354. PubMed
12. Spiegel DA. Efficacy studies of alprazolam in panic disorder. Psychopharmacol Bull. 1998;34(2):191-195. PubMed
13. American Psychiatric Association. Practice Guidelines for the Treatment of Patients With Panic Disorder. Washington, DC: American Psychiatric Association; 1998.
14. Simon NM, Pollack MH. Treatment Refractory Panic Disorder. Psychiatric Clinics of North America: Annual of Drug Therapy. Philadelphia, PA: WB Saunders; 1999.
15. Pollack MH, Simon NM. Pharmacotherapy for Panic Disorder and Agoraphobia. In: Antony M, Stein MB, eds. Oxford Handbook for Anxiety and Related Disorders. Cambridge, England: Oxford University Press; 2008.
16. Barlow DH, Craske MG, Cerny JA, et al. Behavioral treatment of panic disorder. Behav Ther 1989 Spr;20(2):261-282.
17. Craske MG, Barlow DH. Mastery of Your Anxiety and Panic: Therapist Guide (Kindle Edition). New York, NY: Oxford University Press; 2006.
18. Craske MG, DeCola JP, Sachs AD, et al. Panic control treatment for agoraphobia. J Anxiety Disord. 2003;17(3):321-333. doi:10.1016/S0887-6185(02) 00203-7 PubMed
19. Craske MG, Golinelli D, Stein MB, et al. Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting? Psychol Med. 2005;35(11):1645- 1654. doi:10.1017/S003329170500557X PubMed
20. Otto MW, Jones JC, Craske MG, et al. Stopping Anxiety Medication: Panic Control Therapy for Benzodiazepine Continuation (Therapist Guide). Boulder, CO: Graywind Publications; 1996.
21. Barlow DH, Gorman JM, Shear MK, et al. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA. 2000;283(19):2529-2536. doi:10.1001/jama.283.19.2529 PubMed
22. Heldt E, Manfro GG, Kipper L, et al. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission. Behav Res Ther. 2006;44(5):657-665. doi:10.1016/j.brat.2005.05.003 PubMed
23. Otto MW, Pollack MH, Penava SJ, et al. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999;37(8):763-770. doi:10.1016/S0005- 7967(98)00176-4 PubMed
24. First RL, Gibbon M, Williams JBW. Structured Clinical Interview for Axis I DSM-IV Disorders-Patient version (SCID-1/P version 2.0). New York, NY: New York State Psychiatric Institute Biometrics Research Department; 1994.
25. Shear MK, Rucci P, Williams J, et al. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J Psychiatr Res. 2001;35(5):293-296. doi:10.1016/S0022-3956(01)00028-0 PubMed (Pubitemid 32928431)
26. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.
27. Pollack MH, Otto MW, Rosenbaum JF, et al. Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry. 1990;51(suppl A):12-16.
28. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-55. PubMed
29. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62. doi:10.1136/jnnp.23.1.56 PubMed
30. Reiss S, Peterson RA, Gursky DM, et al. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther. 1986;24(1):1-8. doi:10.1016/0005-7967(86)90143-9 PubMed (Pubitemid 16207745)
31. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(supp 3):89-95. doi:10.1097/00004850-199606003- 00015 PubMed
32. Ballenger JC, Wheadon DE, Steiner M, et al. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 1998;155(1):36-42. PubMed (Pubitemid 28037546)
33. Michelson D, Lydiard RB, Pollack MH, et al. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry. 1998;155(11):1570-1577. PubMed (Pubitemid 28512027)
34. Londborg PD, Wolkow R, Smith WT, et al. Sertraline in the treatment of panic disorder: a multi-site, doubleblind, placebo-controlled, fixed-dose investigation. Br J Psychiatry. 1998;173:54-60. doi:10.1192/bjp.173.1.54 PubMed (Pubitemid 28312204)
35. Wade AG, Lepola U, Koponen HJ, et al. The effect of citalopram in panic disorder. Br J Psychiatry. 1997;170:549-553. doi:10.1192/bjp.170.6.549 PubMed
36. Pollack MH, Rapaport MH, Clary CM, et al. Early response to sertraline as a predictor of 12-week outcome in panic disorder. Presented at the 37th annual meeting of the American College of Neuropsychopharmacology; December 14-18, 1998; Las Croabas, Puerto Rico.
37. Pollack MH, Rapaport MH, Fayyad R, et al. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. J Psychiatr Res. 2002;36(4):229-236. doi:10.1016/S0022-3956(02)00010-9 PubMed (Pubitemid 34626373)
38. Marcus SM, Gorman J, Shear MK, et al. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy. Am J Psychiatry. 2007;164(2):273-275. doi:10.1176/appi.ajp. 164.2.273 PubMed (Pubitemid 46318565)
39. Roy-Byrne PP, Craske MG, Stein MB, et al. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry. 2005;62(3):290-298. doi:10.1001/archpsyc.62.3.290 PubMed (Pubitemid 40990974)
40. van Apeldoorn FJ, van Hout WJ, Mersch PP, et al. Is a combined therapy more effective than either CBT or SSRI alone? results of a multicenter trial on panic disorder with or without agoraphobia. Acta Psychiatr Scand. 2008;117(4):260-270. doi:10.1111/j.1600-0447.2008.01157.x PubMed
41. Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord. 2005;88(1):27-45. doi:10.1016/j.jad.2005.05.003 PubMed (Pubitemid 41160411)
42. Furukawa TA, Watanabe N, Churchill R. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry. 2006;188:305-312. doi:10.1192/bjp.188.4.305 PubMed
43. Heldt E, Manfro GG, Kipper L, et al. Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital. Psychother Psychosom. 2003;72(1):43-48. doi:10.1159/000067188 PubMed (Pubitemid 35478111)